glp-1 and parkinson's Repurposing Receptor Agonists for Disease: Current Evidence Future Opportunities | Pharmaceutical Medicine BQURA | R&D News -

Chronic migraine sufferers taking GLP-1 drugs were about 10% less likely to need ER care for a migraine attack compared to those taking a standard first-line migraine drug, researchers are scheduled to report at an upcoming meeting of the American Academy of Neurology in Chicago

[36] Low vitamin D levels are a possible contributing factor to osteoarthritis symptoms, including pain and loss of joint function

In controlled studies, glutathione supplementation increased peroxisome proliferator-activated receptor- coactivator-1 (PGC-1) protein levels by 25% and mitochondrial DNA biogenesis by 53% in skeletal muscle, indicating enhanced mitochondrial function supporting exercise capacity

Many men struggle with weight gain despite consistent efforts with diet and exercise, especially as metabolism slows with age